Study to look at lung cancer in southern Illinois – WAND

Study to look at lung cancer in southern Illinois WAND SPRINGFIELD, Ill. (AP) - A 2-year study will look for the reason the treatment of lung cancer is lagging in southern Illinois. Previous research has shown that lung cancer death rates and cases of lung cancer are higher in southern Illinois than in ... and more »

Tags: Cancer, cancer death rates, Ill., lung, lung cancer, lung cancer death, previous research, reason, southern Illinois, southern IllinoisWANDSPRINGFIELD, study, treatment of lung cancer, year

Smoking Still Leading Lung Cancer Cause, but Fewer in U.S. are Puffing

By Lynette Summerill HERWriter February 6, 2012 - 9:28pm For the first time since cancer statistics have been monitored, fewer US women are getting lung cancer and dying from the disease. According to the Annual Report to the Nation on the Status of ...
See all stories on this topic » Tags: annual report, Cancer, cancer statistics, February, HERWriter, lung, lung cancer, Lynette Summerill, time, US

Anti-Cancer Agent, Tarceva Condition for Approval (All Patients Surveillance …

Tarceva® was originally approved in 2007 for "nonresectable recurrent and advanced non-small cell lung cancer which is aggravated following chemotherapy." At the time of approval, condition for approval was set as "1; a post-marketing surveillance of ...
See all stories on this topic » Tags: approval, cell, cell lung cancer, lung, lung cancer, non small cell lung cancer, quot, small cell lung cancer, Tarceva

Researchers Develop Drug To Block Gene Mutation Causing Lung Cancer

Lung cancer is usually associated with smoking, but a gene mutation puts some people at risk even if they don't smoke. A gene mutation called ALK causes cancer tumors to grow. The gene is found in forms of lung cancer affecting thousands of non-smokers ...
See all stories on this topic » Tags: Cancer, cancer tumors, forms of lung cancer, gene, Gene Mutation, lung, lung cancer, mutation, smokers, smoking

Research and Markets: Lung Cancer – Pipeline Review, H1 2012 – Business Wire (press release)

Research and Markets: Lung Cancer - Pipeline Review, H1 2012 Business Wire (press release) Global Markets Direct's, 'Lung Cancer - Pipeline Review, H1 2012', provides an overview of the Lung Cancer therapeutic pipeline. This report provides information on the therapeutic development for Lung Cancer, complete with latest updates, ... and more »

Tags: Cancer, global markets, H, lung, lung cancer, Markets, pipeline, raquo, research, Review, therapeutic development

Next Page »